compounded semaglutide crackdown news november 2025 GLP-1s Become Illegal, Price Cuts Roll Out Compound versions of GLP-1 drugs
Description
However, semaglutides share is projected to decline to 37% by 2035, as tirzepatide emerges as the new market leader
And I was like, whoa, whoa, whoa
and (3) real-world sales via telehealth/online channels are underreported in the topline numbers analysts track, so the "slowdown" may be partly a data-visibility problem, not a demand problem
Window 15 days What Was Measured Increased treadmill endurance at 25 mg/kg IP daily
Puede que pierdan 50, pero seguirn siendo 300
